Article citationsMore>>

Hughes, E.G., Fedorkow, D.M., Daya, S., Sagle, M.A., Van de Koppel, P. and Collins, J.A. (1992) The Routine Use of Gonadotropin-Releasing Hormone Agonists Prior to In Vitro Fertilization and Gamete Intrafallopian Transfer: A Meta-Analysis of Randomized Controlled Trials. Fertility and Sterility, 58, 888-896.
https://doi.org/10.1016/S0015-0282(16)55430-2

has been cited by the following article:

• TITLE: GnRH Antagonist Protocol: Is It Effective for Expected Poor Ovarian Responders with Tubal Factor Undergoing IVF?

  AUTHORS: Weijie Xing, Haiyan Lin, Qingxue Zhang

  KEYWORDS: Poor Ovarian Responders, GnRH Antagonist Protocol, GnRH Agonist Protocol

  JOURNAL NAME: Advances in Reproductive Sciences, Vol.5 No.4, October 24, 2017

  ABSTRACT: Background: This study aimed to determine if the gonadotropin releasing hormone (GnRH) antagonist protocol is optimal for expected poor ovarian responders with tubal factor undergoing in vitro fertilization-embryo transfer (IVF-ET). Methods: A total of 341 IVF-ET cycles were retrospectively identified. The following inclusion criteria were applied: age ≥ 40 years and patients with tubal factors. The cycles were divided into two groups: a GnRH antagonist group (157 cycles) and a GnRH agonist group (184 cycles). Results: The duration of stimulation and the total doses of gonadotropin in the GnRH agonist group were significantly more than those in the GnRH antagonist group (P